You searched for "product"

1163 results found

The polyp shrinker

Inflammatory markers, including T2 cells beta common (βc) cytokines IL-3, IL5 and granulocyte-macrophage colony-stimulating factor (GM-CSF), are known to play an important role in chronic rhinosinusitis with nasal polyps (CRSwNP). CSL311, a monoclonal antibody (mAb), was developed to target human...

Remembering how to speak

Reminiscence therapy (RT) is an approach that provides people with dementia opportunities to recount nostalgic memories and access thoughts for communication. It is one of the most commonly used therapies in aged care settings. The aim of RT is to...

The electromagnetic larynx

Current treatment options for a bilateral vocal cord palsy (tracheostomy, posterior cordotomy, arytenoidectomy) are suboptimal, with a focus primarily on a static means of airway restoration at the expense of voice production and potentially swallow safety. This paper reports on...

Developmental stuttering: a speech-motor impairment with sensory aspects

In treating patients who stutter, understanding the effects of sensory input (i.e. auditory input) can help to direct therapeutic approaches. Sensory processing has been identified as a contributory factor in several diagnoses, notably autism and ADHD [1], however it has...

saniVENT - sanitizing air-exchanging system from Puma Soundproofing

Puma Soundproofing design, test and manufacture certified soundproof booths for professionals in the medical field.

Carleton Medical Ltd, continuation of Lumenis CO2 support

In line with the announcement from Boston Scientific informing customers that they will cease global production of the Lumenis range of CO2 lasers at the end of 2024, Carleton Medical Ltd wish to reassure continuation of service.

Lockdown has been bad for children, but it might mean they don’t need surgery anymore

Our editor’s choice for this edition reviews an article looking at the effects of lockdown on symptom prevalence in children with adenotonsillar diseases. In this unprecedented COVID-19 era that we are all living and working in, risk assessment has taken...

Sugammadex

Scott Russell is an anaesthetist with an almost unrivalled experience of complex head and neck surgery, and has seen all manner of new ideas come and go. However, in this article he describes a new pharmaceutical agent that is already...

ERS 2025

Get ready to be part of the global rhinology community at the ERS 2025 Congress, taking place from 22–25 June 2025 in Budapest, Hungary. This premier event is set to welcome over 1700 participants from across the world, including rhinologists,...

Harnessing technology for the benefit of children with significant communication difficulties

This article describes future needs in provision and research in the field of augmentative and alternative communication (AAC) aids for children with significant communication difficulties. The authors highlight the needs of users and the opportunities that technology could provide in...

Treating middle ear conditions in developing countries

This month’s journal issue discussed global health in otolaryngology with this paper focusing on the management of chronic middle ear disease in the developing world. Chronic suppurative otitis media (CSOM) is more common in developing countries. The reason for this...

Great gains in groups: language led dementia

The number of people living with dementia is increasing as our population increases and delivering relevant and timely services can be a challenge. Group intervention provides a method of delivering services to a larger number of people and can have...